Tags

Type your tag names separated by a space and hit enter

Interleukin-6 blockade treatment for COVID-19 associated cytokine release syndrome in a patient with poorly controlled chronic myeloid leukaemia.
Br J Haematol. 2020 08; 190(3):e128-e130.BJ

Authors+Show Affiliations

Hillingdon Hospitals NHS Foundation Trust, Uxbridge, UK.Hillingdon Hospitals NHS Foundation Trust, Uxbridge, UK.Department of Haematology, Hillingdon Hospitals, Hillingdon, UK.Hillingdon Hospitals NHS Foundation Trust, Uxbridge, UK.

Pub Type(s)

Case Reports
Journal Article

Language

eng

PubMed ID

32480422

Citation

Ranger, Amita, et al. "Interleukin-6 Blockade Treatment for COVID-19 Associated Cytokine Release Syndrome in a Patient With Poorly Controlled Chronic Myeloid Leukaemia." British Journal of Haematology, vol. 190, no. 3, 2020, pp. e128-e130.
Ranger A, Haji R, Kaczmarski R, et al. Interleukin-6 blockade treatment for COVID-19 associated cytokine release syndrome in a patient with poorly controlled chronic myeloid leukaemia. Br J Haematol. 2020;190(3):e128-e130.
Ranger, A., Haji, R., Kaczmarski, R., & Danga, A. (2020). Interleukin-6 blockade treatment for COVID-19 associated cytokine release syndrome in a patient with poorly controlled chronic myeloid leukaemia. British Journal of Haematology, 190(3), e128-e130. https://doi.org/10.1111/bjh.16901
Ranger A, et al. Interleukin-6 Blockade Treatment for COVID-19 Associated Cytokine Release Syndrome in a Patient With Poorly Controlled Chronic Myeloid Leukaemia. Br J Haematol. 2020;190(3):e128-e130. PubMed PMID: 32480422.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - Interleukin-6 blockade treatment for COVID-19 associated cytokine release syndrome in a patient with poorly controlled chronic myeloid leukaemia. AU - Ranger,Amita, AU - Haji,Ruby, AU - Kaczmarski,Richard, AU - Danga,Akila, Y1 - 2020/06/26/ PY - 2020/6/2/pubmed PY - 2020/8/14/medline PY - 2020/6/2/entrez KW - chronic myeloid leukaemia KW - coronavirus KW - tocilizumab SP - e128 EP - e130 JF - British journal of haematology JO - Br. J. Haematol. VL - 190 IS - 3 SN - 1365-2141 UR - https://www.unboundmedicine.com/medline/citation/32480422/Interleukin_6_blockade_treatment_for_COVID_19_associated_cytokine_release_syndrome_in_a_patient_with_poorly_controlled_chronic_myeloid_leukaemia_ L2 - https://doi.org/10.1111/bjh.16901 DB - PRIME DP - Unbound Medicine ER -